The Cancer Focus Fund is a unique oncology-focused investment fund established in partnership with The University of Texas MD Anderson Cancer Center. We invest in promising cancer therapies in late preclinical development. Our objective is to provide financial support to accelerate the development of these therapeutics together with the clinical trials expertise and infrastructure of MD Anderson.

We provide both capital and translational research expertise with the goal of accelerating the development of therapies to lead to better outcomes for patients while generating returns for investors.